{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:00:59Z","timestamp":1789988459482,"version":"4.0.1"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Type I neurofibromatosis (NF1) represents an autosomal dominant inherited genodermatosis predisposing to tumor occurrence, caused by mutations in the NF1 gene, clinically characterized by the impairment of skin pigmentation, dermal neurofibromas, neuro-psychiatric involvement, and Lisch nodules. The initially defined diagnostic criteria were revised in 2021 to facilitate the diagnosis in young children who present only with skin pigmentation anomalies or a positive family history of NF1. Hemochromatosis (HC) is a genetic disorder consisting of systemic iron overload due to a defect in hepcidin. The mutations are commonly located in the HFE gene. The clinical picture is associated with joint pain, hyperpigmentation, hepatomegaly, etc. Genetic testing is mandatory for the diagnosis of HC. Case Presentation: The aim of this case report is to underline the importance of a multidisciplinary approach for a precise diagnosis. A 17-year-old male teenager with a past medical history of multiple abdominal surgical interventions presented to the emergency department for diarrhea and abdominal pain. The physical examination revealed weight deficit, caf\u00e9-au-lait macules, axillary and inguinal freckling, and mild abdominal tenderness. Laboratory evaluation revealed high CRP, mild leucocytosis and lymphopenia. The surgical consult ruled out an acute surgical cause. The abdominal X-ray, stool culture, fecal cytology, urinalysis and urine culture were negative, but ferritin level and serum iron level were very high. Ophthalmological consult described a Lisch nodule. Multiplex Ligation-dependent Probe Amplification (MLPA) genetic testing found no deletions or duplications within the NF1 gene. The clinical evolution was favorable under third-generation cephalosporin, but the ferritin and serum iron levels remain elevated. The Whole-Exome Sequencing (WES) identified a heterozygous pathogenic variant in the NF1 gene, i.e., chr17:29560075CA&gt;C, NF1(NM_001042492.3):c.3556del; p.(Ile1186SerfsTer29); rs2151435407, but also revealed a homozygous pathogenic variant in the HFE gene, i.e., chr6:26090951C&gt;G, HFE(NM_000410.4):c.187C&gt;G; p.(His63Asp), rs1799945, which is associated with hereditary HC. Conclusions: The overlapping dermatological findings of both NF1 and HC might lead to diagnostic delays. The holistic approach to all pediatric patients presenting with particular hyperpigmentation involves thorough laboratory investigations, neurological, ophthalmological, cardiological and genetic examinations. In the absence of DNA Copy Number Variations (CNVs) that can be identified rapidly and cost-effectively by MLPA, sequencing is indicated to analyze small DNA variations, especially when two conditions with similar clinical pictures coexist.<\/jats:p>","DOI":"10.3390\/children13091266","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:38Z","timestamp":1789981298000},"page":"1266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["One Clinical Picture, Two Clinical Entities: A Case Report and Literature Review of Neurofibromatosis and Hemochromatosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Lorena Elena","family":"Melit","sequence":"first","affiliation":[{"name":"Department of Pediatrics II, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu-Mures, 540142 Targu Mures, Romania"},{"name":"Pediatrics Clinic II, Clinical County Mures Hospital, 540142 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-4469","authenticated-orcid":false,"given":"Reka","family":"Borka Balas","sequence":"additional","affiliation":[{"name":"Department of Pediatrics I, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu-Mures, 540142 Targu Mures, Romania"},{"name":"Pediatrics Clinic I, County Emergency Clinical Hospital of T\u00e2rgu Mure\u0219, 540136 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4297-9988","authenticated-orcid":false,"given":"Florin","family":"Tripon","sequence":"additional","affiliation":[{"name":"Department of Genetics and Cellular and Molecular Biology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu-Mures, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu Alexandru","family":"Prisca","sequence":"additional","affiliation":[{"name":"Pediatric Surgery and Orthopedics Clinic, County Emergency Clinical Hospital of T\u00e2rgu Mure\u0219, 540136 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Toth","sequence":"additional","affiliation":[{"name":"Pediatric Surgery and Orthopedics Clinic, County Emergency Clinical Hospital of T\u00e2rgu Mure\u0219, 540136 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Stangaciu","sequence":"additional","affiliation":[{"name":"Pediatrics Clinic II, Clinical County Mures Hospital, 540142 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Najjar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics II, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu-Mures, 540142 Targu Mures, Romania"},{"name":"Pediatrics Clinic II, Clinical County Mures Hospital, 540142 Targu-Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-021-02410-z","article-title":"Challenges in the Diagnosis of Neurofibromatosis Type 1 (NF1) in Young Children Facilitated by Means of Revised Diagnostic Criteria Including Genetic Testing for Pathogenic NF1 Gene Variants","volume":"141","author":"Cooper","year":"2022","journal-title":"Hum. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archderm.141.1.71","article-title":"Prevalence of Neurofibromatosis 1 in German Children at Elementary School Enrollment","volume":"141","author":"Lammert","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"(1988). Neurofibromatosis: Conference Statement. National Institutes of Health Consensus Development Conference. Arch. Neurol., 45, 575\u2013578.","DOI":"10.1001\/archneur.1988.00520290115023"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised Diagnostic Criteria for Neurofibromatosis Type 1 and Legius Syndrome: An International Consensus Recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18016","DOI":"10.1038\/nrdp.2018.16","article-title":"Haemochromatosis","volume":"4","author":"Brissot","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.molmed.2011.07.004","article-title":"Iron Disorders of Genetic Origin: A Changing World","volume":"17","author":"Brissot","year":"2011","journal-title":"Trends Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","article-title":"Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment","volume":"139","author":"Pietrangelo","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(15)01315-X","article-title":"Haemochromatosis","volume":"388","author":"Powell","year":"2016","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/neup.12149","article-title":"Aceruloplasminemia","volume":"35","author":"Miyajima","year":"2015","journal-title":"Neuropathology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bcmd.2011.07.004","article-title":"A Novel N491S Mutation in the Human SLC11A2 Gene Impairs Protein Trafficking and in Association with the G212V Mutation Leads to Microcytic Anemia and Liver Iron Overload","volume":"47","author":"Island","year":"2011","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000112726","article-title":"A New Case of Human Atransferrinemia with a Previously Undescribed Mutation in the Transferrin Gene","volume":"118","author":"Aslan","year":"2007","journal-title":"Acta Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2010-01-261875","article-title":"How I Treat Hemochromatosis","volume":"116","author":"Adams","year":"2010","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/hep.23879","article-title":"A Phase 1\/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis","volume":"52","author":"Phatak","year":"2010","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1155\/2012\/676824","article-title":"Dietary Iron Intake and Serum Ferritin Concentration in 213 Patients Homozygous for the HFEC282Y Hemochromatosis Mutation","volume":"26","author":"Gordeuk","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/hep.20242","article-title":"Patient and Graft Survival after Liver Transplantation for Hereditary Hemochromatosis: Implications for Pathogenesis","volume":"39","author":"Crawford","year":"2004","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2016.11.010","article-title":"Therapeutic Potential of Hepcidin\u2014The Master Regulator of Iron Metabolism","volume":"115","author":"Vyoral","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e3150","DOI":"10.1097\/MD.0000000000003150","article-title":"Hepcidin: A Promising Therapeutic Target for Iron Disorders. A Systematic Review","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine"},{"key":"ref_18","unstructured":"Barton, J.C., and Parker, C.J. (2024). HFE-Related Hemochromatosis. GeneReviews\u00ae [Internet], University of Washington."},{"key":"ref_19","unstructured":"(2026, September 13). Human Phenotype Ontology. Available online: https:\/\/hpo.jax.org\/browse\/disease\/ORPHA:465508."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/jdv.20098","article-title":"Dermatologic Manifestations of Hereditary Hemochromatosis: A Systematic Review","volume":"39","author":"Akbarialiabad","year":"2025","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Szczerbinska, A., Kasztelan-Szczerbinska, B., Rycyk-Bojarzynska, A., Kocki, J., and Cichoz-Lach, H. (2024). Hemochromatosis\u2014How Not to Overlook and Properly Manage \u201cIron People\u201d\u2014A Review. J. Clin. Med., 13.","DOI":"10.20944\/preprints202402.1362.v1"},{"key":"ref_22","first-page":"135","article-title":"Cutaneous Expression of Familial Cancer Syndromes","volume":"101","author":"Andersen","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kerekes, K., Boostani, M., Metyovinyi, Z., Kiss, N., and Medvecz, M. (2026). Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1. J. Clin. Med., 15.","DOI":"10.3390\/jcm15020475"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.2021011338","article-title":"Hemochromatosis Classification: Update and Recommendations by the BIOIRON Society","volume":"139","author":"Girelli","year":"2022","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1182\/hematology.2024000568","article-title":"Diagnosis and Management of Hereditary Hemochromatosis: Lifestyle Modification, Phlebotomy, and Blood Donation","volume":"2024","author":"Girelli","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Santangelo, A., Chelleri, C., Tomasino, M., Pasquinucci, M., Cappozzo, F., Striano, P., Diana, M.C., and Scala, M. (2025). Caf\u00e9-Au-Lait Macules in Neurofibromatosis Type 1: Birthmark or Biomarker?. Cancers, 17.","DOI":"10.3390\/cancers17091490"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.3892\/mmr.2016.5760","article-title":"Molecular Screening Strategies for NF1-like Syndromes with Caf\u00e9-Au-Lait Macules","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s11689-024-09565-6","article-title":"Unraveling Neuronal and Metabolic Alterations in Neurofibromatosis Type 1","volume":"16","author":"Botero","year":"2024","journal-title":"J. Neurodev. Disord."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","article-title":"An Update on the Central Nervous System Manifestations of Neurofibromatosis Type 1","volume":"139","author":"Nix","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Veres, K., Nagy, B., Ember, Z., Bene, J., Hadzsiev, K., Medvecz, M., Szab\u00f3, L., and Szalai, Z.Z. (2025). Increased Phenotype Severity Associated with Splice-Site Variants in a Hungarian Pediatric Neurofibromatosis 1 Cohort: A Retrospective Study. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010146"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pinti, E., Nemeth, K., Staub, K., Lengyel, A., Fekete, G., and Haltrich, I. (2021). Diagnostic Difficulties and Possibilities of NF1-like Syndromes in Childhood. BMC Pediatr., 21.","DOI":"10.1186\/s12887-021-02791-0"},{"key":"ref_32","unstructured":"(2026, August 26). View of Neurofibromatosis Type 1-Associated Tumors in Children. Available online: https:\/\/turkjpediatr.org\/article\/view\/6461\/3391."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e240184","DOI":"10.57264\/cer-2024-0184","article-title":"Selumetinib for Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas That Can\u2019t Be Removed by Surgery, and Impact on How the Condition Affects Caregivers: A Plain Language Summary","volume":"14","author":"Dinikina","year":"2025","journal-title":"J. Comp. Eff. Res."},{"key":"ref_34","unstructured":"(2026, September 13). BGI Whole Exome Sequencing. Available online: https:\/\/www.bgi.com\/global\/science-detail\/whole-exome-sequencing."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","article-title":"Phenotypic Expression of a Spectrum of Neurofibromatosis Type 1 (NF1) Mutations Identified through NGS and MLPA","volume":"395","author":"Tsipi","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_37","first-page":"852","article-title":"Gastrointestinal Manifestations of Neurofibromatosis Type 1 (Recklinghausen\u2019s Disease): Clinicopathological Spectrum with Pathogenetic Considerations","volume":"5","author":"Agaimy","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13244-018-0648-8","article-title":"Spectrum of Gastrointestinal Lesions of Neurofibromatosis Type 1: A Pictorial Review","volume":"9","author":"Garrouche","year":"2018","journal-title":"Insights Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","article-title":"Emerging Genotype\u2013Phenotype Relationships in Patients with Large NF1 Deletions","volume":"136","author":"Mautner","year":"2017","journal-title":"Hum. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/jccm-2022-0007","article-title":"RAF-1 Mutation Associated with a Risk for Ventricular Arrhythmias in a Child with Noonan Syndrome and Cardiovascular Pathology","volume":"8","year":"2022","journal-title":"J. Crit. Care Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0168-8278(00)80415-8","article-title":"Haemochromatosis in the New Millennium","volume":"32","author":"Powell","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","article-title":"A Novel MHC Class I-like Gene Is Mutated in Patients with Hereditary Haemochromatosis","volume":"13","author":"Feder","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jmg.34.4.275","article-title":"Global Prevalence of Putative Haemochromatosis Mutations","volume":"34","author":"Pointon","year":"1997","journal-title":"J. Med. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nrgastro.2009.201","article-title":"Genetic Mechanisms and Modifying Factors in Hereditary Hemochromatosis","volume":"7","author":"Weiss","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/10906570050114803","article-title":"Geography of HFE C282Y and H63D Mutations","volume":"4","author":"Pointon","year":"2000","journal-title":"Genet. Test."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"729S","DOI":"10.3945\/jn.110.130351","article-title":"HFE Gene Variants Affect Iron in the Brain1\u20133","volume":"141","author":"Nandar","year":"2011","journal-title":"J. Nutr."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:08:57Z","timestamp":1789985337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/9\/1266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["children13091266"],"URL":"https:\/\/doi.org\/10.3390\/children13091266","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}